Non-viral Methods for Ex Vivo Cell & Gene Therapy: Is the Future Non-viral?
In this podcast, our experts explore the types and benefits of non-viral methods for ex vivo cell and gene therapy as well as the readiness of electroporation-based technologies for use in GMP manufacturing.
To listen to the podcast or to download its written summary (PDF), please fill out the form.
Topics discussed include:
- What non-viral methods are currently used in the cell and gene therapy environment?
- What are the advantages and disadvantages of utilizing non-viral technology for ex vivo cell therapy?
- Cell types used in cell therapy applications can be difficult to transfect using non-viral means. How can these challenges be overcome?
- What unique advantages does an electroporation-based method offer?
- What non-viral technologies are currently being used in clinical or commercial applications based on ex vivo modifications?
Panelists:
- Valeria Annibaldi, PhD, Group Leader R&D Transfection, Lonza
- Andrea Toell, PhD, Senior Product Manager, Lonza
This podcast has been produced in collaboration with BioInsights.
